Reproduction Abstracts

The International Colloquium on Hyperemesis Gravidarum was supported by grants from the Burrough’s Wellcome Fund, Bikkja Foundation, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R13HD115385). Additional support was provided by NGM Biopharmaceuticals, Hyperemesis Education and Research Foundation, International Collaboration for Hyperemesis Gravidarum Research, and Harmonia Healthcare.

Author Disclosures

Marlena Fejzo, PhD: Consultant for NGMBio, Harmonia Healthcare and Stock owner of Harmonia Healthcare, NGMBio

Stephen O’Rahilly, MD: Employee of University of Cambridge, grant/research support from Medical Research Council, Wellcome Trust, NIHR Consultant for Pfizer, AstraZeneca, Marea Therapeutics, Courage Therapeutics, Northsea Therapeutics, Third Rock Ventures and stock owner of Marea Therapeutics and Courage Therapeutics

Amy Valent, DO: Grant/Research Support from Dexcom and Mannkind Consultant Dexcom (unpaid), Mannkind (unpaid)

Kate Maslin, PhD: Employee of University of Plymouth, Grant/Research Support from University of Plymouth, Sir Halley Stewart Trust. Speakers Bureau/Honoraria for non-CME for British Dietetic Association and Wiley (book publishers) Consultant/Advisory Board for National Institute of Health and Clinical Excellence (UK)

Andrew Housholder, MD: Consultant for NGM Biopharmaceuticals

Kimber MacGibbon, RN: Hyperemesis Education and Research Foundation Employee of HER Foundation, Speakers Bureau/Honoraria for non-CME for Texas WIC, Consultant/Advisory Board for Harmonia Healthcare Consultant

Margaret Riley, JD: UnitedHealth/stock ownership

Joanne Lancaster, PhD: Employee of NGM Biopharmaceuticals